News from oric pharmaceuticals A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 10, 2019, 08:46 ET ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...


Aug 28, 2019, 08:43 ET ORIC to Participate in Citi's 14th Annual Biotech Investor Conference

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...


Aug 08, 2019, 08:54 ET ORIC Pharmaceuticals Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...


Jul 09, 2019, 07:52 ET ORIC Pharmaceuticals Appoints Lori Friedman, PhD, as Chief Scientific Officer

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...


May 28, 2019, 09:22 ET ORIC Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on making cancer treatments more effective by addressing mechanisms...


Apr 02, 2019, 12:58 ET ORIC Pharmaceuticals Presents Evidence of Glucocorticoid Receptor-Mediated Cancer Treatment Resistance at the AACR Annual Meeting

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on the discovery and development of novel therapies against...


Mar 06, 2019, 08:03 ET ORIC Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on the discovery and development of novel therapies against...


Mar 04, 2019, 08:45 ET ORIC Pharmaceuticals Appoints Edna Chow Maneval, PhD, as Senior Vice President of Clinical Development

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on the discovery and development of novel therapies against...


Feb 20, 2019, 07:35 ET ORIC Pharmaceuticals to Participate in the 8th Annual SVB Leerink Global Healthcare Conference

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on the discovery and development of novel therapies against...


Jan 02, 2019, 07:42 ET ORIC Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on discovery and development of novel therapies against...


Nov 26, 2018, 08:33 ET ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer

ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers,...


Nov 19, 2018, 08:45 ET ORIC Pharmaceuticals to Present at Upcoming Investor Conferences

ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers,...


Oct 22, 2018, 07:47 ET ORIC to Participate at BTIG Biotech Conference

ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers,...


Sep 17, 2018, 07:49 ET ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer

ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers,...


Aug 30, 2018, 08:33 ET ORIC to Participate at Citi 13th Annual Biotech Investor Conference

ORIC Pharmaceuticals, a clinical-stage oncology company focused on discovery and development of novel therapies against treatment-resistant cancers,...


Oct 27, 2017, 08:35 ET ORIC Pharmaceuticals Announces First Subject Dosed in Phase 1 Clinical Study of Novel GR Antagonist with Planned Development for Oncology

ORIC Pharmaceuticals ("ORIC"), a privately held oncology company focused on the discovery and development of drugs to address treatment resistant...


Dec 02, 2015, 07:30 ET ORIC Pharmaceuticals Announces $53 Million Series B Financing to Support Discovery and Development of Novel Therapies for Treatment-Resistant Cancers

ORIC Pharmaceuticals, a cancer therapy company focused on the discovery and development of small-molecule drugs that target treatment-resistant...